BioAffinity Technologies Beta vs. Net Income
The market value of BioAffinity Technologies is measured differently than book value, which reflects BioAffinity accounting equity. Value and price for BioAffinity Technologies are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that BioAffinity Technologies' intrinsic value and market price are different measures derived from different inputs. For BioAffinity Technologies, key inputs include a profit margin of -2.17%, ROE of -2.45%, and revenue of 9.36 M. Market price reflects the current exchange level formed by active bids and offers.
BioAffinity Technologies Net Income vs. Beta Fundamental Analysis
Comparative ratio models evaluate BioAffinity Technologies's market value against peer multiples. bioAffinity Technologies Warrant stands at number one for beta across the peer group. It is rated below average for net income across the peer group . Net Loss is dropping compared to historical levels. BioAffinity Technologies reported -8.14 Million in Net Loss for the previous period. Comparative pricing ratios position BioAffinity Technologies within industry norms.BioAffinity Net Income vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
BioAffinity Technologies |
| = | 2.44 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
BioAffinity Technologies |
| = | -9.04 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
BioAffinity Net Income Comparison
BioAffinity Technologies is currently under evaluation for net income across the peer group.
Beta Analysis
Market upswings tend to lift BioAffinity Technologies more than average, but downturns carry a proportionally larger impact on returns.
BioAffinity Technologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioAffinity Technologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioAffinity Technologies will eventually generate negative long term returns. The profitability progress is the general direction of BioAffinity Technologies' change in net profit over the period of time. It can combine multiple indicators of BioAffinity Technologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -3.6 M | -3.8 M | |
| Operating Income | -8.1 M | -7.7 M | |
| Income Before Tax | -8.1 M | -8.5 M | |
| Total Other Income Expense Net | -86.7 K | -91 K | |
| Net Loss | -8.1 M | -8.5 M | |
| Income Tax Expense | 13.4 K | 7.9 K | |
| Net Interest Income | -86.1 K | -90.4 K | |
| Interest Income | 20.3 K | 19.2 K | |
| Net Loss | -8.1 M | -8.5 M | |
| Net Loss | -25.71 | -27.00 | |
| Income Quality | 0.72 | 0.46 | |
| Net Income Per E B T | 0.90 | 0.80 |
BioAffinity Profitability Driver Comparison
Profitability drivers for BioAffinity Technologies are the financial and operational factors that most directly influence its earnings. Investors must contend with a wide range of external shocks - from regulatory changes to commodity price swings - that can disrupt BioAffinity Technologies' financial results.
Earnings per Share Projection vs Actual
Use BioAffinity Technologies in pair-trading
Pair trading with BioAffinity Technologies can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
BioAffinity Technologies Pair Trading
bioAffinity Technologies Warrant Pair Trading Analysis
Using correlated positions as BioAffinity Technologies substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track bioAffinity Technologies Warrant closely enough to maintain equivalent risk and return.
The correlation of BioAffinity Technologies with other assets is a key diversification metric. Pairing BioAffinity Technologies with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for BioAffinity Technologies can be used to frame hedging context. The view can be extended across sectors or other related groups.Use Investing Themes to Complement your BioAffinity Technologies position
Using bioAffinity Technologies Warrant inside a theme workflow gives investors a structured way to compare related stocks, funds, ETFs, and crypto assets before allocating capital. The practical benefit is that the selected idea can be tuned either for higher upside or for tighter risk control.
Did You Try This Idea?
Run Farming Thematic Idea Now
Farming
Companies producing farming products and providing services for farmers. The Farming theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for BioAffinity Stock Analysis
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash position to determine if your portfolio needs rebalancing | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |